AIM 16 February 2023 NOTICE 16/02/2023 - 07:00 NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM Pursuant to AIM Rule 41 the following...
eeds-based pharmaceutical firm - Notes cancellation of its shares on AIM from Thursday, after it entered into administ ...
4d Pharma PLC 15 February 2023 4D pharma plc (in administration) Cancellation of admission to trading on AIM Leeds, UK, 15 February 2023 - 4D...
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...
4d Pharma PLC 02 February 2023 4D pharma plc (in administration) 4D pharma Announces Updated Results from the Renal Cell Carcinoma Cohort of the...
4d Pharma PLC 16 January 2023 4D pharma Announces Result of General Meeting Leeds, UK - January 16, 2023 - 4D pharma plc (AIM: DDDD) (in...
4D Pharma PLC on Friday said it was seeking shareholder approval for a USD15.0 million cash raise, as it works to lif ...
4d Pharma PLC 30 December 2022 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON...
4D Pharma PLC said on Wednesday that its Blautix phase 2 clinical trial results showed the treatment had a positive e ...
4d Pharma PLC 16 November 2022 4D pharma's Blautix(R) Phase II Clinical Trial Results Published in Alimentary Pharmacology & Therapeutics...
4d Pharma PLC 10 November 2022 4D pharma Announces Two Presentations at The Society for Immunotherapy of Cancer Annual Meeting (SITC 2022) Leeds...
4d Pharma PLC 05 October 2022 4D pharma Announces Two Presentations at The Society for Immunotherapy of Cancer Annual Meeting (SITC 2022) Leeds...
4d Pharma PLC 29 September 2022 4D pharma plc (in administration) Delay to publication of Interim Results Update on Suspension of Trading on AIM...
eeds, England-based pharmaceutical company - Releases its publication of pre-clinical research on mice regarding live ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads